First-trimester drug use and congenital disorders.

Author: AseltonP, HunterJ R, JickH, MilunskyA, StergachisA

Paper Details 
Original Abstract of the Article :
The authors determined the prevalence of certain major congenital disorders among live-born infants of 6509 mothers in a prepaid health plan for the 30-month period of January 1, 1980 through June 30, 1982 who used a wide variety of drugs during the first trimester of pregnancy. The results were sim...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/3982720

データ提供:米国国立医学図書館(NLM)

First-Trimester Drug Use: A Journey Through the Desert of Pregnancy

Pregnancy is a delicate and complex journey, often accompanied by questions about medication use. This research delves into the potential impact of first-trimester drug use on the development of major congenital disorders in newborns. The researchers embarked on a comprehensive study, examining the prevalence of certain congenital disorders in a large cohort of infants whose mothers used a wide variety of drugs during the first trimester of pregnancy. Their findings offer insights into the potential risks and benefits of medication use during this critical period.

Navigating the Shifting Sands of Medication Use

The study, like a scientific expedition through the vast desert of pregnancy, revealed no strong associations between the commonly used drugs and the congenital disorders studied. These findings, like a well in the desert, offer reassurance to expectant mothers seeking to navigate the complex landscape of medication use during pregnancy. The study emphasizes the importance of individual risk assessments and close monitoring, ensuring that pregnant women receive the most appropriate and safe care throughout their journey.

A Journey of Informed Decision-Making

This research highlights the importance of evidence-based decision-making when considering medication use during pregnancy. It's like a compass guiding us through the shifting sands of potential risks and benefits, reminding us to rely on scientific evidence and consult with healthcare professionals to make informed choices. The study underscores the importance of ongoing research to better understand the potential effects of medications on fetal development, ultimately seeking to ensure the safest possible journey for both mother and child.

Dr. Camel's Conclusion

This research provides valuable insights into the complex world of first-trimester drug use and its potential impact on fetal development. It's like a guidebook for navigating the desert of pregnancy, offering reassurance and guidance for expectant mothers seeking to make informed decisions about their health and the health of their unborn child. The study emphasizes the importance of continued research and open communication with healthcare providers, ensuring that pregnant women receive the most appropriate and safe care throughout their journey.

Date :
  1. Date Completed 1985-05-01
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

3982720

DOI: Digital Object Identifier

3982720

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.